Concepedia
Publication | Open Access
Regulation of Tumor Progression by Extracellular Galectin-3
129
Citations
93
References
2008
Year
Two CD95 (APO-1/Fas) signaling pathways
Carsten Scaffidi
The EMBO Journal
Signal TransductionSignaling PathwayMolecular PathwayApoptosisSignaling Pathways +4
1998
3K
Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles
Clotilde Théry, Muriel Boussac, P. Véron, +4
The Journal of Immunology
2001
1.5K
Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction
Umesh C. Sharma, Saraswati Pokharel, Thomas J. van Brakel, +8
Circulation
2004
927
Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation
Michael Demetriou, Maria Granovsky, Sue Quaggin, +1
Nature
InflammationAutoimmune DiseaseT-regulatory CellImmunologyAutoimmunity +9
894
Expression of galectin-3 modulates T-cell growth and apoptosis.
Ri‐Yao Yang, Daniel K. Hsu, F T Liu
Proceedings of the National Academy of Sciences
Nwgr MotifViral ImmunityImmune RegulationImmunologyCell Death +7
1996
780
Human Galectin-3 Is a Novel Chemoattractant for Monocytes and Macrophages
Hideki Sano, Daniel K. Hsu, Lan Yu, +5
2000
520
Galectin-3 Precipitates as a Pentamer with Synthetic Multivalent Carbohydrates and Forms Heterogeneous Cross-linked Complexes
Nisar Ahmad, Hans‐Joachim Gabius, Sabine André, +6
Journal of Biological Chemistry
517
Galectin-3 Induces Endothelial Cell Morphogenesis and Angiogenesis
Pratima Nangia‐Makker, Yuichiro Honjo, Rebecca Sarvis, +4
American Journal Of Pathology
443
Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways
Ayoub Suliman, Arh Lam, Rakesh Datta
Oncogene
Signal TransductionMitochondrial FunctionCell SignalingPhysiologyApoptosis +8
417
Inhibition of Human Cancer Cell Growth and Metastasis in Nude Mice by Oral Intake of Modified Citrus Pectin
Pratima Nangia‐Makker, Victor Hogan, Yuichiro Honjo, +4
JNCI Journal of the National Cancer Institute
2002
Page 1